Product Information |
Product name |
Isavuconazole |
CAS No. |
241479-67-4 |
Molecular Formula |
C22H17F2N5OS |
Molecular Weight |
437.473 |
Molecular Structure |
|
Quality Standard |
98% up by HPLC |
Appearance |
White to yellow powder |
COA of Isavuconazole
ITEMS |
STANDARDS |
RESULTS |
Appearance |
White to yellow powder |
Conforms |
Identification |
The peak position of T001-M9 in the test solution was the same as that in the related solution. |
Conforms |
Solubility |
Practically insoluble in water,soluble |
Conforms |
Melting point |
120℃~126℃ |
121.5℃~123.0℃ |
Specific Optical Rotation |
[α]D20:-25.0°~-34.0° |
-29.1° |
Related substances |
Any single impurity≤0.5% |
0.17% |
Total impurity ≤1.0% |
0.23% |
|
Loss on drying |
≤1.0% |
0.09% |
Assay |
≥ 98% |
99.77% |
Conclusion |
The above items have been tested according with the Enterprise Standard for the product,the results comply with Specifications . |
Usage |
Isavuconazole is a new type of triazole antifungal drug. On the basis of retaining the potent anti-Candida activity of the first-generation triazole drugs, it has enhanced the activity against filamentous fungal infection and is a broad-spectrum antifungal drug. Compared with other azoles, the special molecular structure of isavuconazole sulfate (containing 2 chiral centers) enables the orientation of the triazole ring to engage with the binding pocket of the fungal CYP51 protein, thus giving it a broader antifungal spectrum , including fungi resistant to azoles (such as itraconazole, voriconazole, and posaconazole), have good antibacterial activity.
*Products under the patent are only for R&D use